Bronchiectasis Severity Index Calculator
Estimate Bronchiectasis Severity Index, BSI, using age, body mass index, airflow limitation, breathlessness, exacerbation burden, microbiology, radiology, and hospitalization history. This interactive tool is designed for education and clinical reference, not as a substitute for individual medical judgment.
Enter patient data
Results
Enter all fields, then click Calculate BSI to see the total score, risk class, and score breakdown.
What is a bronchiectasis severity index calculator?
A bronchiectasis severity index calculator is a structured scoring tool that combines several high value clinical variables into one practical summary score. Instead of looking at age, spirometry, symptoms, imaging, microbiology, and exacerbation history in isolation, the calculator integrates them into a single Bronchiectasis Severity Index, commonly called BSI. Clinicians often use this framework to stratify patients into mild, moderate, or severe risk groups. That stratification helps support decisions about follow up intensity, airway clearance planning, microbiology surveillance, pulmonary rehabilitation, and the need for more specialist review.
Bronchiectasis itself is a chronic lung condition characterized by permanently widened bronchi, impaired mucus clearance, recurrent infection, and ongoing airway inflammation. Severity can vary widely. Some people have infrequent symptoms and relatively preserved lung function, while others have repeated exacerbations, chronic colonization with pathogenic organisms, progressive breathlessness, and recurrent hospital admissions. A calculator is useful because disease burden is multidimensional. A patient may have modest spirometric impairment but severe exacerbation frequency, or vice versa. The BSI attempts to capture that broader picture.
This page provides a premium interactive bronchiectasis severity index calculator, plus a detailed guide that explains how the score works, why it matters, what each variable means, and how to interpret the result responsibly. The output should be considered an educational or decision support aid. It is not a substitute for full clinical assessment, sputum culture review, chest imaging interpretation, oxygenation status, comorbidity assessment, and clinician judgment.
How the BSI score is calculated
The Bronchiectasis Severity Index is built from eight core domains that were selected because they predict clinically meaningful outcomes. Each variable contributes a set number of points. The total score then maps to a risk class. Higher scores indicate greater expected disease burden and a higher likelihood of future adverse outcomes such as hospitalization, recurrent exacerbations, poorer quality of life, and mortality.
| BSI variable | Criteria | Points |
|---|---|---|
| Age | Under 50 years, 50 to 69 years, 70 to 79 years, 80 years or older | 0, 2, 4, 6 |
| Body mass index | BMI below 18.5 kg/m² | 2 |
| FEV1 percent predicted | More than 80, 50 to 80, 30 to 49, below 30 | 0, 1, 2, 3 |
| MRC dyspnea score | Scores 1 to 3, score 4, score 5 | 0, 2, 3 |
| Exacerbations in previous year | 0 to 2, 3 or more | 0, 2 |
| Hospital admission in previous 2 years | No, yes | 0, 5 |
| Microbiology | No chronic colonization, other organisms, chronic Pseudomonas aeruginosa | 0, 1, 3 |
| Radiology | 3 or more lobes involved or cystic bronchiectasis | 1 |
These point values show an important principle of the BSI. Not all predictors carry the same weight. A prior hospital admission adds 5 points because severe exacerbations requiring inpatient care are strongly associated with worse future outcomes. Age can also contribute substantially. By contrast, radiologic extent adds just 1 point. This does not mean imaging is unimportant. It means that in the final predictive model, its independent weighting is smaller than certain other variables.
Risk categories used by the calculator
| Total BSI score | Risk category | Typical clinical interpretation |
|---|---|---|
| 0 to 4 | Mild | Lower risk profile, often fewer exacerbations, less severe airflow limitation, and lower expected healthcare utilization |
| 5 to 8 | Moderate | Intermediate risk, often warrants closer review of airway clearance adherence, microbiology, vaccination status, and exacerbation prevention |
| 9 or more | Severe | Higher risk profile, often associated with more frequent admissions, chronic colonization, worse symptoms, and a greater need for specialist management |
Clinicians use these bands to support care planning, but the score should never be interpreted in isolation. For example, a patient with a moderate score and repeated hemoptysis or rapid radiologic progression may still need urgent escalation. Likewise, a patient with a severe score who is clinically stable under expert care may not need the same next step as someone with uncontrolled symptoms and recurrent acute episodes.
Why each input matters
Age
Age is included because it captures both physiologic reserve and observed differences in outcomes across bronchiectasis cohorts. Older patients are more likely to have frailty, comorbid disease, and reduced resilience during exacerbations. In the BSI model, age contributes up to 6 points, making it one of the largest weighted domains.
BMI
Low BMI may reflect chronic inflammation, advanced disease burden, inadequate nutritional intake, increased energy expenditure from work of breathing, or all of these at once. A BMI below 18.5 kg/m² adds 2 points. Although only one nutritional threshold is used, the wider clinical lesson is that weight loss and sarcopenia deserve active attention in bronchiectasis management.
FEV1 percent predicted
FEV1 percent predicted is a familiar spirometric marker of airflow limitation. The BSI assigns 0 to 3 points depending on how low the percentage is. Even though bronchiectasis is structurally defined on imaging, functional impairment remains highly informative. Lower FEV1 often correlates with symptom burden, exercise limitation, and future risk.
MRC dyspnea score
The Medical Research Council dyspnea scale is a practical way to quantify breathlessness in daily life. Scores of 4 or 5 increase the BSI. This matters because quality of life in bronchiectasis is driven not only by test results but also by how far the patient can walk, how often they must stop, and whether symptoms interfere with routine tasks.
Exacerbations and hospital admissions
Exacerbation history is central to modern bronchiectasis care. Patients with 3 or more exacerbations in the prior year gain 2 points, and a hospital admission in the previous 2 years adds 5. Those numbers underline a major truth: the future often resembles the recent past. If a patient has been unstable, they are more likely to remain unstable unless treatment, adherence, airway clearance, infection control, or underlying causes are addressed.
Microbiology
Chronic Pseudomonas aeruginosa colonization receives 3 points, while other chronic pathogenic colonization receives 1. Pseudomonas is clinically important because it is associated with more severe disease, more frequent exacerbations, and more challenging treatment decisions. Repeated sputum culture surveillance remains essential even when symptoms appear relatively stable.
Radiologic severity
More extensive disease on imaging, usually defined in the BSI as 3 or more lobes involved or cystic bronchiectasis, adds 1 point. Imaging identifies the structural footprint of disease. The point value is modest, but radiology remains vital for diagnosis, etiology clues, and tracking progression over time.
How to use this bronchiectasis severity index calculator correctly
- Enter the patient age in years.
- Enter the current body mass index, ideally based on recent measured height and weight.
- Enter FEV1 percent predicted from the best available spirometry.
- Select the MRC dyspnea grade that best matches daily limitations.
- Enter the number of exacerbations in the previous year.
- Select whether there has been a hospital admission for severe exacerbation in the previous 2 years.
- Choose microbiology status, paying close attention to chronic Pseudomonas aeruginosa colonization.
- Select whether radiologic disease is extensive or cystic.
- Click Calculate BSI to obtain the total score, category, and a chart showing the contribution of each domain.
The chart is useful because it highlights which specific variables are driving the score. That can guide practical conversation. If the score is high mainly because of prior admission and exacerbation burden, prevention strategies may take center stage. If dyspnea and low FEV1 are dominant, pulmonary rehabilitation, inhaled therapy optimization, and exercise tolerance assessment may be particularly relevant.
Clinical relevance of BSI in everyday practice
Risk stratification influences more than prognosis. It affects how often patients are reviewed, how aggressively airway clearance is reinforced, when prophylactic antibiotic strategies are considered, and how intensively sputum microbiology is monitored. A higher BSI may also prompt broader evaluation for contributing factors such as immunodeficiency, allergic bronchopulmonary aspergillosis, aspiration, connective tissue disease, ciliary disorders, nontuberculous mycobacterial infection, or previous severe respiratory infections.
For multidisciplinary teams, the calculator can improve consistency. A respiratory physician, specialist nurse, physiotherapist, and primary care clinician can all refer to the same risk language. That shared vocabulary makes it easier to prioritize interventions and follow progress over time. If a patient moves from frequent exacerbations to relative stability after airway clearance optimization or long term macrolide therapy, the BSI drivers may change in a meaningful way, even if some structural features remain fixed.
BSI compared with other bronchiectasis scoring tools
The BSI is not the only severity tool in bronchiectasis. Another well known score is FACED, which uses FEV1, age, chronic colonization with Pseudomonas aeruginosa, radiologic extent, and dyspnea. FACED is simpler and efficient, but BSI includes exacerbation frequency, prior hospitalization, and BMI, all of which add practical information about current disease burden and healthcare utilization. Many specialists consider BSI particularly useful when future exacerbation risk and admission risk are central questions.
- BSI strengths: broader multidimensional assessment, includes exacerbations and prior hospitalizations, often valuable for follow up planning.
- FACED strengths: streamlined and easy to calculate, useful for mortality oriented risk grouping.
- Shared limitation: neither score replaces individualized clinical reasoning or captures every relevant comorbidity.
Limitations of a bronchiectasis severity index calculator
Even a strong clinical score has limitations. First, data quality matters. An incorrect exacerbation count or outdated spirometry can distort the final risk category. Second, the BSI does not directly account for every meaningful comorbidity, including severe cardiovascular disease, frailty syndromes, untreated reflux with aspiration, active smoking, or significant immunosuppression. Third, microbiology can change over time, so a single culture snapshot may not reflect persistent colonization. Fourth, a score is less informative during acute instability if the patient needs immediate treatment regardless of numeric risk category.
Another limitation is that patient experience is broader than prognosis alone. Cough frequency, fatigue, sleep disruption, anxiety related to recurrent infections, and socioeconomic barriers to airway clearance adherence may have a major effect on quality of life without always moving the score dramatically. Use the calculator as one lens, not the only lens.
Frequently asked questions
Is a high BSI score a diagnosis?
No. The score does not diagnose bronchiectasis. Diagnosis requires clinical evaluation and imaging, usually high resolution chest CT. The BSI is a severity and risk stratification tool after diagnosis or when the diagnosis is already established.
What counts as chronic Pseudomonas colonization?
Definitions can vary in practice and research protocols. In general, repeated positive sputum cultures over time support chronic colonization. If there is uncertainty, defer to the treating respiratory team and local guideline definitions.
Can the score be used in primary care?
It can be informative in primary care, especially for communicating risk and deciding when to escalate specialist review. However, interpretation is strongest when paired with respiratory assessment, culture data, and imaging review.
How often should BSI be recalculated?
There is no universal interval for every patient, but updating the score after major clinical change, annual review, recurrent exacerbations, or new microbiology findings can be helpful.
Authoritative resources for further reading
If you want deeper reference material, start with these authoritative sources:
- National Heart, Lung, and Blood Institute, Bronchiectasis overview
- MedlinePlus, Bronchiectasis patient information
- National Library of Medicine, open access article on bronchiectasis severity and outcomes
Bottom line
A bronchiectasis severity index calculator transforms complex clinical information into a structured risk estimate that is easier to discuss, compare over time, and use in management planning. The most important value of the tool is not the number alone, but the conversation it creates. A rising score should prompt a careful review of why the disease is worsening. A lower score should not cause complacency if the patient reports significant symptoms or frequent decline. Use the calculator to support evidence informed care, then place the result back into the full clinical picture where it belongs.